| Syndrome of Early Onset Colon Cancers, Hematologic Malignancies & Features of Neurofibromatosis in HNPCC Families with Homozygous Mismatch Repair Gene Mutations |
|
|
|
|
|
|
|
|
|
| Neurofibromatosis 2 (NF2) and Malignant Mesothelioma in a Man with a Constitutional NF2 Missense Mutation |
|
|
|
|
|
|
|
|
|
| Patient Satisfaction of BRCA1/2 Genetic Testing by Women at High Risk for Breast Cancer Participating in a Prevention Trial |
|
|
|
|
|
|
|
|
|
| Key word Index Volume 4 |
|
|
|
|
|
|
|
|
|
| Contents Volume 4 |
|
|
|
|
|
|
|
|
|
| Linkage of a Pedigree Drawing Program and Database to a Program for Determining BRCA Mutation Carrier Probability |
|
|
|
|
|
|
|
|
|
| Long Term Follow-up of HNPCC Gene Mutation Carriers: Compliance with Screening and Satisfaction with Counseling and Screening Procedures |
|
|
|
|
|
|
|
|
|
| Lack of Germ-line Mutations at the Specific BRCA1-IRIS Coding Sequence in 114 Spanish High-risk Breast/ovarian Families |
|
|
|
|
|
|
|
|
|
| BAP1 and Breast Cancer Risk |
|
|
|
|
|
|
|
|
|
| Acknowledgements |
|
|
|
|
|
|
|
|
|
| Survival of Patients with Ovarian Cancer due to a Mismatch Repair Defect |
|
|
|
|
|
|
|
|
|
| Mutational analysis of hMsh6 in Israeli HNPCC and HNPCC-like Families |
|
|
|
|
|
|
|
|
|
| Behavioral and Economic Impact of a Familial History of Cancers |
|
|
|
|
|
|
|
|
|
| MLH1 and MSH2 Mutations in Colombian Families with Hereditary Nonpolyposis Colorectal Cancer (Lynch syndrome) – Description of Four Novel Mutations |
|
|
|
|
|
|
|
|
|
| Introduction |
|
|
|
|
|
|
|
|
|
| Evolution of the Nomenclature for the Hereditary Colorectal Cancer Syndromes |
|
|
|
|
|
|
|
|
|
| Lynch Syndrome Genes |
|
|
|
|
|
|
|
|
|
| The Tumor Spectrum in the Lynch Syndrome |
|
|
|
|
|
|
|
|
|
| Frequency of Familial Colon Cancer and Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) in a Large Population Database |
|
|
|
|
|
|
|
|
|
| Use of Microsatellite Instability and Immunohistochemistry Testing for the Identification of Individuals at Risk for Lynch Syndrome |
|
|
|
|
|
|
|
|
|
| Clinical Description of the Lynch Syndrome [Hereditary Nonpolyposis Colorectal Cancer (HNPCC)] |
|
|
|
|
|
|
|
|
|
| The Incidence of Lynch Syndrome |
|
|
|
|
|
|
|
|
|
| Surveillance in Lynch Syndrome |
|
|
|
|
|
|
|
|
|
| Gynecologic Cancers in Lynch Syndrome/HNPCC |
|
|
|
|
|
|
|
|
|
| Guest editorial |
|
|
|
|
|
|
|
|
|
| Referrals of patients to colorectal cancer genetics services in south-east Scotland |
|
|
|
|
|
|
|
|
|
| SISE matters: the Sum of Information on Seventy-yr-old Equivalents measures pedigree information content when assessing the risk of HNPCC in a family |
|
|
|
|
|
|
|
|
|
| Abdominal desmoid in familial adenomatous polyposis presenting as a pancreatic cystic lesion |
|
|
|
|
|
|
|
|
|
| High prevalence of two BRCA1 mutations, 4154delA and 5382insC, in Latvia |
|
|
|
|
|
|
|
|
|
| An unusual case of Turcot’s syndrome associated with ileal adenocarcinoma, intestinal non-Hodgkin’s lymphoma, and duodenal adenocarcinoma. Review of the classification and genetic basis of Turcot’s sy |
|
|
|
|
|
|
|
|
|
| The CHEK2 1100delC allele is not relevant for risk assessment in HNPCC and HBCC Spanish families |
|
|
|
|
|
|
|
|
|
| Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort |
|
|
|
|
|
|
|
|
|
| Screening for exonic copy number mutations at MSH2 and MLH1 by MAPH |
|
|
|
|
|
|
|
|
|
| Informing one’s family about genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a retrospective exploratory study |
|
|
|
|
|
|
|
|
|
| Measurement of psychological factors associated with genetic testing for hereditary breast, ovarian and colon cancers |
|
|
|
|
|
|
|
|
|
| The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li–Fraumeni-like kindreds |
|
|
|
|
|
|
|
|
|
| The Tyr978X BRCA1 mutation: occurrence in non-Jewish Iranians and haplotype in French-Canadian and non-Ashkenazi Jews |
|
|
|
|
|
|
✓ |
|
non-Jewish Iranians; French-Canadian; non-Ashkenazi Jews |
| Ratio of male to female births in the offspring of BRCA1 and BRCA2 carriers |
|
|
|
|
|
|
|
|
|
| A high frequency of germline BRCA1/2 mutations in western Sweden detected with complementary screening techniques |
|
|
|
|
|
|
|
|
|
| A comparison of the phenotype and genotype in adenomatous polyposis patients with and without a family history |
|
|
|
|
|
|
|
|
|
| APC and β-catenin protein expression patterns in HNPCC-related endometrial and colorectal cancers |
|
|
|
|
|
|
|
|
|
| The BRCA1 exon 13 duplication in the Swedish population |
|
|
|
|
|
|
|
|
|
| Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients |
|
|
|
|
|
|
|
|
|
| Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations |
|
|
|
|
|
|
|
|
|
| The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation |
|
|
|
|
|
|
|
|
|
| Pheochromocytoma – where are we? Where should we go? A medical and scientific odyssey |
|
|
|
|
|
|
|
|
|
| SDHC mutations in hereditary paraganglioma/pheochromocytoma |
|
|
|
|
|
|
|
|
|
| Paragangliomas of the head and neck: diagnosis and treatment |
|
|
|
|
|
|
|
|
|
| Imaging of pheochromocytoma and paraganglioma |
|
|
|
|
|
|
|
|
|
| Mutations of the SDHB and SDHD genes |
|
|
|
|
|
|
|
|
|
| Central nervous system manifestations in VHL: genetics, pathology and clinical phenotypic features |
|
|
|
|
|
|
|
|
|
| Multiple endocrine neoplasia type 2 |
|
|
|
|
|
|
|
|
|
| Ophthalmological manifestations in VHL and NF 1: pathological and diagnostic implications |
|
|
|
|
|
|
|
|
|
| Pheochromocytoma-associated syndromes: genes, proteins and functions of RET, VHL and SDHx |
|
|
|
|
|
|
|
|
|
| Pheochromocytoma in von Hippel–Lindau disease and neurofibromatosis type 1 |
|
|
|
|
|
|
|
|
|
| Molecular pathogenesis of MEN2-associated tumors |
|
|
|
|
|
|
|
|
|
| Instructions for Authors |
|
|
|
|
|
|
|
|
|
| Origins of the Leeds Castle Polyposis Group |
|
|
|
|
|
|
|
|
|
| History of the International Collaborative Group on Hereditary NonPolyposis Colorectal Cancer |
|
|
|
|
|
|
|
|
|
| Author Index |
|
|
|
|
|
|
|
|
|
| Programme |
|
|
|
|
|
|
|
|
|